HBsAg Rapid Test Device (Plasma)

Call For Pricing.

Model Number: NH-43987

Brand: Niche Healthcare

The HBsAg Rapid Test Device (Whole blood/Serum/Plasma) is a rapid visual immunoassay for the qualitative presumptive detection of HBsAg in human whole blood, serum or plasma spec imens. This kit is intended to be used as an aid in the diagnosis of HBV infection.

 

Description

Catalog No. HBsAg-4012 Format Device
Specimen Whole Blood/Serum/Plasma Certificate None CE
Reading Time 15 minutes Test/Kit 40
Storage Temperature 4-30°C Shelf Life 2 Years
Sensitivity >99.9% Specificity >99.9%
Accuracy >99.9% Principle Visual Interpretation

 

The HBsAg Rapid Test Device (Whole blood/Serum/Plasma) can offer several healthcare benefits in the National Health Service (NHS) or any healthcare system. Here are potential benefits:

  1. Early Detection of HBV Infection: The rapid test allows for the early detection of Hepatitis B surface antigen (HBsAg) in whole blood, serum, or plasma, enabling timely diagnosis of Hepatitis B virus (HBV) infection.

  2. Prompt Initiation of Treatment: Early detection facilitates the prompt initiation of antiviral treatment, improving the chances of successful management and reducing the risk of complications associated with chronic hepatitis B, such as liver cirrhosis and liver cancer.

  3. Prevention of Vertical Transmission: Identifying pregnant women with HBV infection through screening can help in preventing vertical transmission of the virus from mother to child. This involves implementing appropriate interventions, such as antiviral therapy and vaccination for newborns.

  4. Prevention of Horizontal Transmission: Rapid testing can contribute to preventing the transmission of HBV in healthcare settings and other environments by identifying individuals with active infection.

  5. Screening High-Risk Populations: Rapid tests are valuable for screening high-risk populations, such as individuals born in regions with high HBV prevalence, people with a history of injection drug use, healthcare workers, and individuals with multiple sexual partners.

  6. Resource Optimization: Rapid tests contribute to efficient resource utilization by providing quick and cost-effective diagnostic information, allowing healthcare providers to prioritize and manage cases more effectively.

  7. Point-of-Care Testing: Rapid tests can be performed at the point of care, providing quick results without the need for sending samples to a laboratory. This expedites decision-making and allows for immediate counseling and treatment initiation.

  8. Public Health Surveillance: Monitoring the prevalence of HBV infections in the population through rapid testing can contribute to public health surveillance efforts. This information helps in planning and implementing preventive measures and public health interventions.

  9. Reduction of Stigma: Early diagnosis through rapid testing may contribute to reducing the stigma associated with HBV infection, as individuals can be informed and supported promptly.

 

Infectious Disease Trials

Infectious disease trials are conducted to address various aspects related to the prevention, treatment, and understanding of diseases caused by infectious agents, such as bacteria, viruses, parasites, or fungi. Here are some reasons for conducting infectious disease trials:

  1. Vaccine Development: Trials are crucial for testing the safety and efficacy of new vaccines aimed at preventing infectious diseases. This includes vaccines for viruses like influenza, human papillomavirus (HPV), and emerging threats like COVID-19.
  2. Antiviral and Antibiotic Testing: Clinical trials assess the effectiveness of new antiviral medications or antibiotics in treating infections. This is particularly important in addressing antibiotic resistance and finding alternative treatments.
  3. Understanding Disease Mechanisms: Trials help researchers understand the mechanisms of infectious diseases, including how pathogens spread, evade the immune system, and cause illness.
  4. Global Health Concerns: Trials play a vital role in addressing global health concerns, such as emerging infectious diseases (e.g., Ebola, Zika, COVID-19) and ongoing challenges like malaria, tuberculosis, and HIV.
  5. Public Health Interventions: Trials evaluate the effectiveness of public health interventions, such as strategies for disease prevention, control, and containment.
  6. Drug and Treatment Development: Researchers conduct trials to develop and test new drugs or treatment regimens for infectious diseases, aiming to improve outcomes for affected individuals.
  7. Surveillance and Epidemiology: Clinical trials contribute to surveillance efforts by providing data on disease prevalence, transmission patterns, and the effectiveness of control measures.

Infectious disease trials are essential for advancing our understanding of these diseases, developing effective interventions, and ultimately improving global public health. They contribute significantly to the development of evidence-based strategies for preventing, treating, and managing infectious diseases.

 

Types of Infections

Types of Infections

 

For more information, contact us 01274 965089 or check out our website at www.nicheofficesolutions.co.uk www.nicheofficesolutions.co.uk/niche-nhs

Further clinical information can be found on our blog page: www.nicheofficesolutions.co.uk/category/niche-healthcare-news

For products not found on our online website, please view our Healthcare catalogues: www.nicheofficesolutions.co.uk/healthcare-catalogues

View our Healthcare YouTube videos Playlist

If you have any additional questions, drop us an email at info@nicheofficesolutions.co.uk 

Reviews

There are no reviews yet.

Be the first to review “HBsAg Rapid Test Device (Plasma)”